Liver Diseases Therapeutics Drugs Market Report

China Liver Diseases Therapeutics Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：222
  • REPORT CODE：GMM1758227
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Liver Diseases Therapeutics Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Shenzhen Kangtai Biological Products

    • Phenex Pharmaceuticals

    • F Hoffmann-La Roche

    • ProMetic Life Sciences

    • Gilead Sciences

    • GlaxoSmithKline

    • Achillion Pharmaceuticals,

    • Verva Pharmaceuticals

    • AbbVie

    • Merck

    • LG Life Sciences

    • Angion Biomedica

    • Bayer

    By Type:

    • Oral

    • Injection

    By Application:

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Liver Diseases Therapeutics Drugs Market Overview 2018-2029

    • 1.1 China Liver Diseases Therapeutics Drugs Industry Development Overview

    • 1.2 China Liver Diseases Therapeutics Drugs Industry Development History

    • 1.3 China Liver Diseases Therapeutics Drugs Industry Market Size (2018-2029)

    • 1.4 China Liver Diseases Therapeutics Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Liver Diseases Therapeutics Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

      • 1.4.2 China Liver Diseases Therapeutics Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • 1.5 China Liver Diseases Therapeutics Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Liver Diseases Therapeutics Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Liver Diseases Therapeutics Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Liver Diseases Therapeutics Drugs Market Analysis by Region

      • 1.6.1 North China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Liver Diseases Therapeutics Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Liver Diseases Therapeutics Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Liver Diseases Therapeutics Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Liver Diseases Therapeutics Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Liver Diseases Therapeutics Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Liver Diseases Therapeutics Drugs Industry Development

    Chapter 3 Liver Diseases Therapeutics DrugsIndustry Chain Analysis

    • 3.1 Liver Diseases Therapeutics Drugs Industry Chain

    • 3.2 Liver Diseases Therapeutics Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Liver Diseases Therapeutics Drugs Market

    • 3.3 Liver Diseases Therapeutics Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Liver Diseases Therapeutics Drugs Market

    Chapter 4 China Liver Diseases Therapeutics Drugs Market, by Type

    • 4.1 China Liver Diseases Therapeutics Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Liver Diseases Therapeutics Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Liver Diseases Therapeutics Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Liver Diseases Therapeutics Drugs Production Volume and Growth Rate of Oral

      • 4.5.2 China Liver Diseases Therapeutics Drugs Production Volume and Growth Rate of Injection

    Chapter 5 China Liver Diseases Therapeutics Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Liver Diseases Therapeutics Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Liver Diseases Therapeutics Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Liver Diseases Therapeutics Drugs Market Size and Growth Rate of Hospital

      • 5.5.2 China Liver Diseases Therapeutics Drugs Market Size and Growth Rate of Clinic

    Chapter 6 China Liver Diseases Therapeutics Drugs Market, by Region

    • 6.1 China Liver Diseases Therapeutics Drugs Production Volume and Production Value, by Region

    • 6.2 China Liver Diseases Therapeutics Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Liver Diseases Therapeutics Drugs Market Analysis

    • 7.1 North China Liver Diseases Therapeutics Drugs Market, by Type

    • 7.2 North China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 8 Central China Liver Diseases Therapeutics Drugs Market Analysis

    • 8.1 Central China Liver Diseases Therapeutics Drugs Market, by Type

    • 8.2 Central China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 9 South China Liver Diseases Therapeutics Drugs Market Analysis

    • 9.1 South China Liver Diseases Therapeutics Drugs Market, by Type

    • 9.2 South China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 10 East China Liver Diseases Therapeutics Drugs Market Analysis

    • 10.1 East China Liver Diseases Therapeutics Drugs Market, by Type

    • 10.2 East China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 11 Northeast China Liver Diseases Therapeutics Drugs Market Analysis

    • 11.1 Northeast China Liver Diseases Therapeutics Drugs Market, by Type

    • 11.2 Northeast China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 12 Southwest China Liver Diseases Therapeutics Drugs Market Analysis

    • 12.1 Southwest China Liver Diseases Therapeutics Drugs Market, by Type

    • 12.2 Southwest China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 13 Northwest China Liver Diseases Therapeutics Drugs Market Analysis

    • 13.1 Northwest China Liver Diseases Therapeutics Drugs Market, by Type

    • 13.2 Northwest China Liver Diseases Therapeutics Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Shenzhen Kangtai Biological Products

        • 14.1.1 Shenzhen Kangtai Biological Products Company Profile

        • 14.1.2 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Phenex Pharmaceuticals

        • 14.2.1 Phenex Pharmaceuticals Company Profile

        • 14.2.2 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 F Hoffmann-La Roche

        • 14.3.1 F Hoffmann-La Roche Company Profile

        • 14.3.2 F Hoffmann-La Roche Liver Diseases Therapeutics Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 ProMetic Life Sciences

        • 14.4.1 ProMetic Life Sciences Company Profile

        • 14.4.2 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Gilead Sciences

        • 14.5.1 Gilead Sciences Company Profile

        • 14.5.2 Gilead Sciences Liver Diseases Therapeutics Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline

        • 14.6.1 GlaxoSmithKline Company Profile

        • 14.6.2 GlaxoSmithKline Liver Diseases Therapeutics Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Achillion Pharmaceuticals,

        • 14.7.1 Achillion Pharmaceuticals, Company Profile

        • 14.7.2 Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Verva Pharmaceuticals

        • 14.8.1 Verva Pharmaceuticals Company Profile

        • 14.8.2 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AbbVie

        • 14.9.1 AbbVie Company Profile

        • 14.9.2 AbbVie Liver Diseases Therapeutics Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Merck

        • 14.10.1 Merck Company Profile

        • 14.10.2 Merck Liver Diseases Therapeutics Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 LG Life Sciences

        • 14.11.1 LG Life Sciences Company Profile

        • 14.11.2 LG Life Sciences Liver Diseases Therapeutics Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Angion Biomedica

        • 14.12.1 Angion Biomedica Company Profile

        • 14.12.2 Angion Biomedica Liver Diseases Therapeutics Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Bayer

        • 14.13.1 Bayer Company Profile

        • 14.13.2 Bayer Liver Diseases Therapeutics Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Liver Diseases Therapeutics Drugs Industry Research Conclusions

    • 15.2 Liver Diseases Therapeutics Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Liver Diseases Therapeutics Drugs Industry Market Size (2018-2029)

    • Figure China Liver Diseases Therapeutics Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Liver Diseases Therapeutics Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Liver Diseases Therapeutics Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Liver Diseases Therapeutics Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Liver Diseases Therapeutics Drugs Market Size and Growth Rate from 2018-2029

    • Figure Liver Diseases Therapeutics Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Liver Diseases Therapeutics Drugs Market Share by Type in 2018

    • Figure China Liver Diseases Therapeutics Drugs Market Share by Type in 2023

    • Figure China Liver Diseases Therapeutics Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Market Share by Application in 2018

    • Figure China Liver Diseases Therapeutics Drugs Market Share by Application in 2023

    • Figure China Liver Diseases Therapeutics Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Liver Diseases Therapeutics Drugs Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Production Volume by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Production Volume Share by Region (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Production Volume Share by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Production Value by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Production Value Share by Region (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Production Value Share by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Sales Volume by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Sales Volume Share by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Sales Value by Region (2018-2023)

    • Table China Liver Diseases Therapeutics Drugs Sales Value Share by Region (2018-2023)

    • Figure China Liver Diseases Therapeutics Drugs Sales Value Share by Region (2018-2023)

    • Table North China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table North China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table North China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table North China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table Central China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table Central China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table South China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table South China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table South China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table East China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table East China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table East China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Liver Diseases Therapeutics Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Liver Diseases Therapeutics Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Liver Diseases Therapeutics Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Liver Diseases Therapeutics Drugs Sales Volume Share by Application (2018-2023)

    • Table Shenzhen Kangtai Biological Products Company Profile

    • Table Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Phenex Pharmaceuticals Company Profile

    • Table Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Company Profile

    • Table F Hoffmann-La Roche Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table ProMetic Life Sciences Company Profile

    • Table ProMetic Life Sciences Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Achillion Pharmaceuticals, Company Profile

    • Table Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Verva Pharmaceuticals Company Profile

    • Table Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table LG Life Sciences Company Profile

    • Table LG Life Sciences Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Angion Biomedica Company Profile

    • Table Angion Biomedica Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Liver Diseases Therapeutics Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US